New blood test detects 90% of aggressive prostate cancer cases, beating current screenings

A new blood test called Stockholm3 detects 90% of aggressive prostate cancer cases, outperforming the traditional PSA test which detects 74%. A study involving 12,000 men found Stockholm3 missed significantly fewer serious cases without increasing unnecessary follow-ups.